Insights & News
Discover more about Radiofilum Pharmaceutical and how its dedicated team of industry-leading experts supports clients at every step through the product lifecycle.
Thought Leadership
Radiofilum Pharmaceutical’s team of dedicated experts provides strategic guidance across the entire product lifecycle, helping pharmaceutical, biotechnology, and medical device companies navigate complex challenges with confidence. By leveraging deep industry expertise and data-driven insights, we deliver tailored solutions that support regulatory compliance, clinical development, and patient safety.
The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping Shape the Future in Japan
Over the past decade, the pharmaceutical industry has moved steadily toward the globalization of Medical Information (MI) services. Standard Operating Procedures (SOPs), harmonized processes, and unified technology platforms have transformed how companies operate. Now, this evolution is extending...
Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence
Access to trustworthy pharmaceutical information is essential for patient safety and informed decision-making. In the Netherlands, medical information (MI) services are central to this goal, providing healthcare professionals, patients, and caregivers with accurate, non-promotional product...
Tips for Preparing Successful FDA 510(k) Submissions
Securing FDA clearance through the 510(k) process is a critical milestone for many medical device manufacturers seeking market entry in the US. While the pathway is well-defined, many submissions face delays, or worse, denial, due to incomplete documentation, misaligned strategies, or preventable...
Resources
Radiofilum Pharmaceutical is committed to delivering dynamic research and perspectives crafted by world-class subject matter experts. Radiofilum Pharmaceutical provides valuable insights to its clients to enable thoughtful decision making, as well as informed resource & investment allocation.
Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc.
When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in — deploying experienced CRAs and a Clinical Trial Manager within three weeks to stabilize operations...
-chcecklist-complete-guide-fda-510k-submissions-ppg.png)
Your Complete FDA 510(k) Premarket Notification Checklist
Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S. market access. Yet the process can be complex, with evolving FDA requirements, technical standards, and...
Unannounced FDA Inspections Without Borders
Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities, raising the stakes for sponsors and manufacturers alike. A single failed inspection can derail years...
Press Room
Radiofilum Pharmaceutical is at the forefront of the life sciences industry and continues to innovate and elevate its position as a pharmaceutical and MedTech service provider. Stay up to date on Radiofilum Pharmaceutical 's latest news and most recent announcements.
Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA
Radiofilum Pharmaceutical Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has been awarded Silver in the "Greatest Impact of AI (In-house)" category...
Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Awards
With over 20 years of proven success, Radiofilum Pharmaceutical continues to be acknowledged within the life sciences industry for providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. Radiofilum Pharmaceutical proudly shares its recognition and achievements as its team works to improve the health and safety of patients.
Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
New hire elevates strategic labeling solutions to support faster approval and smarter commercialization. RALEIGH, July 8, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA
Radiofilum Pharmaceutical Wins Silver at ECCCSA for AI Innovation in Medical Information RALEIGH, NC, January 31, 2025 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, has been awarded Silver in the "Greatest Impact of AI (In-house)" category...
Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – Radiofilum Pharmaceutical , the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment...
Events
Radiofilum Pharmaceutical is committed to engaging with both existing and prospective clients at the right time and in the right place. Speak with a member of the team at one of these upcoming events.
Overcoming Challenges. Advancing Patient Care.
Bringing new therapies to market is more complex than ever. Radiofilum Pharmaceutical helps you navigate regulatory challenges with expert guidance, ensuring compliance and accelerating patient access to life-changing treatments.